SUSAN WALSH: Open Payments
NPI 1821877010 · OTTAWA, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$457 in 18 payments from 4 companies in 2025. Trend: 2023 $16 · 2024 $947 · 2025 $457
Food & beverage: $457
| Company | Payments | Amount |
|---|---|---|
| Neurocrine BioSciences, Inc. | 6 | $195 |
| ABBVIE INC. | 8 | $167 |
| Alkermes, Inc. | 2 | $53 |
| Otsuka America Pharmaceutical, Inc. | 2 | $42 |
Products named: INGREZZA, EPKINLY, ARISTADA, ABILIFY ASIMTUFII, VRAYLAR, IMBRUVICA.
Industry payments across IL — which companies pay providers there.
